Dr. Benjamin Cohen, MD

NPI: 1639339039
Total Payments
$140,217
2024 Payments
$65,708
Companies
16
Transactions
188
Medicare Patients
450
Medicare Billing
$44,976

Payment Breakdown by Category

Consulting$75,044 (53.5%)
Other$44,654 (31.8%)
Research$12,323 (8.8%)
Food & Beverage$4,937 (3.5%)
Travel$3,259 (2.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $75,044 30 53.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $43,754 20 31.2%
Unspecified $12,323 11 8.8%
Food and Beverage $4,937 114 3.5%
Travel and Lodging $3,259 12 2.3%
Honoraria $900.00 1 0.6%

Payments by Type

General
$127,894
177 transactions
Research
$12,323
11 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $49,420 69 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $40,252 17 $0 (2024)
PFIZER INC. $28,777 39 $0 (2024)
Janssen Biotech, Inc. $8,620 33 $0 (2024)
Celgene Corporation $3,564 6 $0 (2024)
Grifols, S.A. $3,278 4 $0 (2018)
Lilly USA, LLC $2,400 1 $0 (2021)
Ferring Pharmaceuticals Inc. $2,274 5 $0 (2024)
Celltrion Healthcare Co., Ltd $900.00 1 $0 (2017)
Janssen Global Services, LLC $425.00 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $65,708 43 Takeda Pharmaceuticals U.S.A., Inc. ($38,437)
2023 $4,767 19 AbbVie Inc. ($4,426)
2022 $14,848 35 ABBVIE INC. ($12,287)
2021 $16,979 29 PFIZER INC. ($12,594)
2020 $13,815 10 AbbVie Inc. ($8,620)
2019 $4,043 11 Janssen Biotech, Inc. ($1,562)
2018 $8,672 21 Grifols, S.A. ($3,278)
2017 $11,386 20 AbbVie, Inc. ($5,729)

All Payment Transactions

188 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/18/2024 PFIZER INC. VELSIPITY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,612.00 General
Category: INFLAMMATION;PAIN
12/05/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,900.00 General
11/08/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,100.00 General
10/30/2024 ABBVIE INC. Travel and Lodging In-kind items and services $698.52 General
10/30/2024 Janssen Global Services, LLC Consulting Fee Cash or cash equivalent $425.00 General
10/30/2024 ABBVIE INC. Food and Beverage In-kind items and services $96.25 General
10/16/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,711.25 General
10/15/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,100.00 General
10/14/2024 ABBVIE INC. RINVOQ (Biological) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: IMMUNOLOGY
10/03/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $4.31 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/30/2024 PFIZER INC. VELSIPITY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,200.00 General
Category: INFLAMMATION;PAIN
09/27/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.58 General
Category: Immunology
09/26/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $2.33 General
Category: INFLAMMATION;PAIN
09/25/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $3.01 General
Category: Immunology
09/12/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $28.52 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/26/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $49.91 General
Category: Immunology
08/21/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $27.72 General
Category: Immunology
07/26/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $17.68 General
Category: Immunology
07/25/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $9.20 General
Category: Immunology
07/17/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $25.09 General
Category: INTERNAL MEDICINE
07/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,486.00 General
07/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,486.00 General
07/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,582.00 General
07/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), PLENVU Food and Beverage In-kind items and services $19.85 General
Category: Gastroenterology
06/27/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $17.54 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT

Research Studies & Clinical Trials

Study Name Company Amount Records
TOFACITINIB CLINICAL PUBLICATION PROGRAM PFIZER INC. $10,030 8
TOFACITINIB IBD CLINICAL PUBLICATION PROGRAM PFIZER INC. $2,180 2
M15-991 AbbVie, Inc. $112.53 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 113 129 $89,812 $11,997
2022 4 101 121 $72,782 $11,225
2021 8 148 170 $99,501 $15,374
2020 5 88 95 $48,187 $6,381
Total Patients
450
Total Services
515
Medicare Billing
$44,976
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 52 68 $28,072 $4,528 16.1%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 28 28 $38,696 $3,622 9.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 17 17 $13,396 $2,208 16.5%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 16 16 $9,648 $1,640 17.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 47 64 $23,746 $4,552 19.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 24 24 $30,144 $3,301 11.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 19 22 $11,566 $2,512 21.7%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 11 11 $7,326 $859.68 11.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 39 47 $17,115 $3,539 20.7%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 12 18 $9,258 $2,148 23.2%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 16 16 $20,720 $2,147 10.4%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 24 24 $13,419 $2,020 15.1%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 17 17 $9,316 $1,835 19.7%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 13 13 $10,638 $1,464 13.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 15 23 $8,655 $1,331 15.4%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 12 12 $10,380 $889.97 8.6%
45380 Biopsy of large bowel using an endoscope Facility 2020 16 16 $21,372 $2,047 9.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 33 35 $11,683 $1,587 13.6%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 12 12 $6,548 $1,278 19.5%
99203 New patient office or other outpatient visit, typically 30 minutes Facility 2020 14 14 $4,430 $755.62 17.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 13 18 $4,154 $714.21 17.2%

About Dr. Benjamin Cohen, MD

Dr. Benjamin Cohen, MD is a Gastroenterology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1639339039.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Cohen, MD has received a total of $140,217 in payments from pharmaceutical and medical device companies, with $65,708 received in 2024. These payments were reported across 188 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($75,044).

As a Medicare-enrolled provider, Cohen has provided services to 450 Medicare beneficiaries, totaling 515 services with total Medicare billing of $44,976. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Cleveland, OH
  • Active Since 06/10/2008
  • Last Updated 04/08/2020
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1639339039

Products in Payments

  • XELJANZ (Drug) $19,638
  • HUMIRA (Biological) $10,313
  • SKYRIZI (Biological) $10,243
  • Humira (Biological) $6,111
  • TREMFYA (Drug) $5,355
  • VELSIPITY (Drug) $4,814
  • ZEPOSIA (Drug) $3,564
  • STELARA (Biological) $3,266
  • RINVOQ (Biological) $2,534
  • CLENPIQ (Drug) $2,257
  • Inflectra (Biological) $900.00
  • ENTYVIO (Biological) $146.22
  • Skyrizi (Biological) $112.53
  • Entyvio (Biological) $104.67
  • XIFAXAN (Drug) $54.84
  • AMJEVITA (Biological) $40.06
  • CREON (Drug) $27.23
  • DUPIXENT (Biological) $24.75
  • Talicia (Drug) $23.86
  • ADSTILADRIN (Biological) $16.94

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Cleveland